Biological activity of cannabichromene, its homologs and isomers.
Cannabichromene (CBC) is one of four major cannabinoids in Cannabis sativa L. and is the second most abundant cannabinoid in drug-type cannabis. Cannabichromene and some of its homologs, analogs, and isomers were evaluated for antiinflammatory, antibacterial, and antifungal activity. Antiinflammatory activity was evaluated by the carrageenan-induced rat paw edema and the erythrocyte membrane stabilization method. In both tests, CBC was superior to phenylbutazone. Antibacterial activity of CBC and its isomers and homologs was evaluated using gram-positive, gram-negative, and acid-fast bacteria. Antifungal activity was evaluated using yeast-like and filamentous fungi and a dermatophyte. Antibacterial activity was strong, and the antifungal activity was mild to moderate.
D000818:Animals; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D001419:Bacteria / Q000187:drug effects; D002186:Cannabinoids / Q000494:pharmacology* / Q000633:toxicity; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D007536:Isomerism; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D051381:Rats; D011919:Rats, Inbred Strains
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D002186:Cannabinoids; C010695:cannabichromene